Research synthesis only; not medical advice. Dose calculation for any approved or investigational product must be performed by a qualified health-care professional using the exact parameters in the current product labeling or ethics-approved protocol. This page teaches the underlying mathematics, dimensional analysis, and error modes; it does not provide a dose or administration volume for any unapproved peptide.
Dimensional analysis: the foundation
Dimensional analysis is the method of converting between units by multiplying by conversion factors expressed as fractions that equal 1. Every dose calculation involves tracking a set of physical dimensions:
Mass: mg, µg, ng
Volume: mL, µL
Concentration: mg/mL, µg/µL
Time: hour, day, week
Example (classroom only — non-injectable, fictional)
Consider a fictional oral solution for a fictional condition. The label states: 200 mg/5 mL. A caregiver needs to give 120 mg of the fictional drug.
? mL = 120 mg × (5 mL / 200 mg)
= (120 × 5) / 200 mL
= 600/200 mL
= 3 mLEvery term's unit cancels (mg cancels mg), leaving only mL. If the units do not cancel to the desired unit, the calculation setup is wrong.
This example is for dimensional-analysis instruction only. It is not a real product or dose.
Concentration versus dose: a critical distinction
| Term | Definition | Units | Example |
|---|---|---|---|
| Dose | Amount of drug in an order or protocol | mg, µg | 120 mg in the fictional oral classroom example |
| Concentration | Amount per unit volume | mg/mL | 200 mg/5 mL in the fictional oral classroom example |
| Volume | Quantity of solution | mL | A measured volume in a validated product workflow |
| Mass per administration | Also the dose | mg, µg | (concentration × volume) |
A common error is to treat a mass and a volume as interchangeable. They are not; the relationship depends on a verified concentration from the exact product.
Unit prefixes and conversion
| Prefix | Symbol | Factor | Example |
|---|---|---|---|
| milli- | m | 10⁻³ | 1 mg = 0.001 g |
| micro- | µ | 10⁻⁶ | 1 µg = 0.001 mg |
| nano- | n | 10⁻⁹ | 1 ng = 0.001 µg |
Key equivalences for peptide products:
1 mg = 1000 µg
1 mL = 1000 µL
A 1% solution (w/v) = 10 mg/mL (1 g/100 mL)
Significant figures and rounding
Dose calculations should be rounded only under the product-specific policy used by the responsible pharmacist, clinician, or study protocol. Reporting more digits than a validated measurement system can resolve creates false precision. This repository intentionally does not select a device or give rounding outputs for administration.
Common error modes in dose calculation
The 10× error (decimal misplacement)
A misplaced decimal can turn a documented 0.5 mg quantity into 5 mg. This is a 10-fold error before any route or device is considered.
A 10× error is among the most common medication errors in both inpatient and outpatient settings.
Concentration confusion
When a lyophilized product is reconstituted, the label specifies both the quantity of drug and the volume of diluent. Some products require further dilution. Errors occur when:
An operator copies a concentration from a different product or presentation
A calculation assumes a final volume that the validated label does not state
A non-validated preparation is treated as if its actual peptide content and final concentration were known
Unit mismatch
Mixing mg and µg (a 1000× error)
Mixing mL and µL (a 1000× error)
Treating a product-specific biological “unit” as a universal mass or volume; unit definitions are not interchangeable across products
Ratio and proportion errors
If a pharmacist compounds a dilution and writes "Dilute to 10 mL" when the correct instruction is "Add 10 mL" (or vice versa), the resulting concentration differs by the displacement volume of the solute.
What online "peptide calculators" do
Several websites and mobile applications accept a peptide mass (in mg) and a desired dose (in mg or µg) and return a withdrawal volume. These tools typically:
Assume a fixed reconstitution volume that may not match a validated product instruction
Assume complete dissolution and no volume displacement from the lyophilized cake
Apply a simple proportion while treating all displayed inputs as verified
Ignore product-specific factors: aggregation losses, overfill, preservative concentration, viscosity, adsorption to container
Provide no quality or sterility assessment
Why they cannot establish a safe or appropriate dose:
The reconstitution volume is product-specific and cannot be inferred from peptide mass alone
The actual peptide content per vial carries labeled overfill that accounts for holdup in the vial and syringe dead space; the calculator may assume a different overfill factor
The concentration after reconstitution cannot be validated by the user without an assay
The dose-to-volume relationship assumes that the entire contents are recoverable, which may not be true for viscous or adsorptive formulations
No calculator can account for individual patient factors (renal function, volume of distribution, concomitant medications, indication) that determine appropriate dose
Auditing a calculation without turning it into an administration tool
For an approved product or ethics-approved study, a qualified professional can audit whether the documented prescribed quantity, labeled concentration, unit definitions, route, patient parameters, and product presentation all come from the same current source. Units should cancel correctly, rounding policy should be explicit, and an independent checker should reproduce the result under the applicable institutional procedure. A mathematically consistent result is still unsafe if any input is unverified, the product is unapproved or inauthentic, or the calculation is being used outside the labeled/protocol context.
This atlas therefore does not accept user-entered peptide mass or desired dose, does not calculate an administration volume, and does not recommend a device.
Sources
Institute for Safe Medication Practices. ISMP's List of High-Alert Medications in Community/Ambulatory Healthcare. 2021. https://www.ismp.org/recommendations/high-alert-medications-community-ambulatory-list
USP General Chapter
<795>Pharmaceutical Compounding — Nonsterile Preparations. USP–NF. Rockville, MD: United States Pharmacopeia; 2026.USP General Chapter
<797>Pharmaceutical Compounding — Sterile Preparations. USP–NF. Rockville, MD: United States Pharmacopeia; 2026.FDA. Guidance for Industry: Safety Considerations for Product Design to Minimize Medication Errors. 2016. https://www.fda.gov/media/98641/download
Cohen MR, ed. Medication Errors. 2nd ed. American Pharmacists Association; 2007. ISBN 978-1582120625.
Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA. 1997;277(4):312--317. https://doi.org/10.1001/jama.1997.03540280050033